SOFIA (Bulgaria), October 14 (SeeNews) – The board of Bulgarian veterinary drug maker Biovet said on Friday that the joint buyout bid of majority owner Huvepharma and minority shareholder Opportunity 2009 is a fair offer, which won't affect negatively the company and its employes once it is accepted.